研究者
J-GLOBAL ID:201801006546455897   更新日: 2021年10月20日

中島 誠

Makoto Nakashima
所属機関・部署:
研究分野 (1件): 腫瘍生物学
論文 (18件):
  • Kazu Okuma, Madoka Kuramitsu, Toshihiro Niwa, Tomokuni Taniguchi, Yumiko Masaki, Gohzoh Ueda, Chieko Matsumoto, Rieko Sobata, Yasuko Sagara, Hitomi Nakamura, et al. Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan. Retrovirology. 2020. 17. 1. 26-26
  • Masumichi Saito, Hiroo Hasegawa, Shunsuke Yamauchi, So Nakagawa, Daisuke Sasaki, Naganori Nao, Michikazu Tanio, Yusaku Wada, Takahiro Matsudaira, Haruka Momose, et al. A high-throughput detection method for the clonality of Human T-cell leukemia virus type-1-infected cells in vivo. International journal of hematology. 2020
  • Emi Ikebe, Sahoko Matsuoka, Kenta Tezuka, Madoka Kuramitsu, Kazu Okuma, Makoto Nakashima, Seiichiro Kobayashi, Junya Makiyama, Makoto Yamagishi, Seiichi Oyadomari, et al. Activation of PERK-ATF4-CHOP pathway as a novel therapeutic approach for efficient elimination of HTLV-1-infected cells. Blood Advances. 2020. 4. 9. 1845-1858
  • Yamagishi M, Hori M, Fujikawa D, Ohsugi T, Honma D, Adachi N, Katano H, Hishima T, Kobayashi S, Nakano K, et al. Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas. Cell reports. 2019. 29. 8. 2321-2337
  • Makiyama J, Kobayashi S, Watanabe E, Ishigaki T, Kawamata T, Nakashima M, Yamagishi M, Nakano K, Tojo A, Watanabe T, et al. CD4+ CADM1+ cell percentage predicts disease progression in HTLV-1 carriers and indolent adult T-cell leukemia/lymphoma. Cancer science. 2019
もっと見る
MISC (4件):
  • Yamagishi M, Kobayashi S, Makiyama J, Araya N, Nakashima M, Iwanaga M, Utsunomiya A, Tanaka Y, Watanabe T, Yamano Y, et al. Transcriptomic and epigenomic characteristics of HTLV-1 infected cells in asymptomatic carriers, HAM/TSP, and ATLL. The 19th International conference on Human Retrovirology. 2019. 45-45
  • 牧山 純也, 小林 誠一郎, 渡辺 恵理, 石垣 知寛, 川俣 豊隆, 中島 誠, 山岸 誠, 中野 和民, 東條 有伸, 渡邉 俊樹, et al. CD4+CADM1+細胞集団の割合はHTLV-1キャリアおよびインドレントATLの予後を予測する(Proportion of CD4+CADM1+ population predicts disease progression in HTLV-1 AC and indolent ATL). 臨床血液. 2018. 59. 9. 1597-1597
  • Makoto Yamagishi, Dai Fujikawa, Daisuke Honma, Nobuaki Adachi, Shota Nakagawa, Makoto Hori, Naoya Kurokawa, Ai Soejima, Kazumi Nakano, Tadanori Yamochi, et al. Polycomb-Dependent Epigenetic Landscape in Adult T Cell Leukemia (ATL); Providing Proof of Concept for Targeting EZH1/2 to Selectively Eliminate the HTLV-1 Infected Population. BLOOD. 2015. 126. 23
  • Tomiteru Togano, Makoto Nakashima, Mariko Watanabe, Kazuo Umezawa, Toshiki Watanabe, Masaaki Higashihara, Ryouichi Horie. Inhibition of NF-kappa B Activation Augments the Effect of 5-Azacytidine On Acute Myeloid Leukemia Cell Line. BLOOD. 2012. 120. 21
※ J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る